Primary cilia are antenna-like structures that are present on the surface of most cells in the human body. The cilia are essential mediators of communication between the different cells in the body. If the cilia are defective, this communication is disrupted, and the cells are unable to appropriately regulate several important cellular processes, which ultimately can lead to severe diseases that may affect nearly every organ and tissue in the body, in the developing embryo as well as in the adult.
Research performed in recent years has shown that the ability of these small communicating antennas (cilia) to receive and transmit signals from the environment is critically dependent on transport of specific signaling receptors in and out of cilia. The cilia are found on the surface of almost every single cell in the body, and by constantly monitoring the environment, they control basic cellular behaviors, such as when a cell has to divide or migrate to a different position in the body during embryonic development.
In the developing embryo there is for instance the Sonic hedgehog (Shh) signaling pathway, which is one of the most important signaling pathways in our body that regulates the development of several major organs, such as kidney and brain. Defects in cilia that affect Shh signaling, or mutations in genes that code for Shh signaling proteins, can therefore lead to severe diseases called "ciliopathies" where the kidney, brain and many other organs in the body are defective. In addition, defective Shh signaling has also been shown to cause brain tumors in children and adults.
Despite the physiological importance of cilia for human health and disease, the molecular mechanism by which cilia receive and transmit signals is still not fully understood. A new study from the Cilia Group (Department of Biology, University of Copenhagen), published in Nature Communications, has now provided important new information that may help to resolve this long-time mystery.
Associate professor Lotte Bang Pedersen from Department og Biology says, 'In this study, we found that a cholesterol-binding membrane protein called Caveolin (CAV1) is located at the base of the cilium and has a central role in the regulating the cilium's ability to activate the Shh signaling pathway. And the short version is that we now finally know how extremely complex and dynamic activation of this pathway is -- and we have identified a key switch that controls this activation.'
While Caveolin is required for activation of the Shh pathway at the base of the cilium, the new study identified two additional proteins -- the kidney disease protein Nephrocystin-4 and a molecular motor protein called KIF13B -- that are both required for regulating Caveolin at the cilium, and which therefore also contribute to activation of Shh signaling. It was already known that Nephrocystin-4 regulates the cilium's ability to receive and transmit signals, and that mutations in Nephrocystin-4 cause diseases of the kidney and other organs.
With the new study we are one step closer to understanding the molecular mechanism by which these diseases occur so we can develop better treatments for "ciliopathy" patients in the future. Moreover, with the identification of KIF13B as an important regulator of signaling at the cilium it may only be a matter of time before disease-causing mutations in KIF13B are identified in human patients with cilia-related diseases.
Cite This Page: